Human papillomavirus vaccine uptake among 9‐ to 17‐year‐old girls

BACKGROUND: Since 2006, the human papillomavirus (HPV) vaccine has been routinely recommended for preadolescent and adolescent girls in the United States. Depending on uptake patterns, HPV vaccine could reduce existing disparities in cervical cancer. METHODS: HPV vaccination status and reasons for n...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 117; no. 24; pp. 5612 - 5620
Main Authors Wong, Charlene A., Berkowitz, Zahava, Dorell, Christina G., Anhang Price, Rebecca, Lee, Jennifer, Saraiya, Mona
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 15.12.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BACKGROUND: Since 2006, the human papillomavirus (HPV) vaccine has been routinely recommended for preadolescent and adolescent girls in the United States. Depending on uptake patterns, HPV vaccine could reduce existing disparities in cervical cancer. METHODS: HPV vaccination status and reasons for not vaccinating were assessed using data from the 2008 National Health Interview Survey. Households with a girl aged 9‐17 years were included (N = 2205). Sociodemographic factors and health behaviors associated with vaccine uptake were assessed using multivariate logistic regression. RESULTS: Overall, 2.8% of 9‐ to 10‐year‐olds, 14.7% of 11‐ to 12‐year‐olds, and 25.4% of 13‐ to 17‐year‐olds received at least 1 dose of HPV vaccine; 5.5% of 11‐ to 12‐year‐olds and 10.7% of 13‐ to 17‐year‐olds received all 3 doses. Factors associated with higher uptake in multivariate analysis included less than high school parental education, well‐child check and influenza shot in the past year, and parental familiarity with HPV vaccine. Parents' primary reasons for not vaccinating were beliefs that their daughters did not need vaccination, that their daughters were not sexually active, or had insufficient vaccine knowledge. More parents with private insurance (58.0%) than public (39.8%) or no insurance (39.5%) would pay $360‐$500 to vaccinate their daughters. CONCLUSIONS: Less than one quarter of girls aged 9‐17 years had initiated HPV vaccination by the end of 2008. Efforts to increase HPV uptake should focus on girls in the target age group, encourage providers to educate parents, and promote access to reduced‐cost vaccines. Cancer 2011;. © 2011 American Cancer Society. Less than one quarter of girls 9‐17 years old initiate human papillomavirus (HPV) vaccination. Efforts to increase HPV uptake should focus on vaccinating the target age group, encouraging providers to give parents vaccine information, and promoting access to reduced‐cost vaccines and well‐child check‐ups.
Bibliography:Charlene Wong and Jennifer Lee completed this project during a 1‐year fellowship with The CDC Experience, a public/private partnership supported by a grant to the CDC Foundation from External Medical Affairs, Pfizer Inc.
Fax: (770) 488‐4639
We thank Shannon Stokely and Robin Curtis for their contributions.
The findings and conclusions in this study are those of the authors and do not necessarily reflect the official position of the Department of Health and Human Services or the Centers for Disease Control and Prevention, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.26246